Radiotherapy may enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancers harboring features of immunotherapy resistance: evidence of the abscopal effect.
Radiotherapy to a single tumor lesion prior to immune checkpoint inhibition enhances systemic anti-tumor immune response in advanced non-small cell lungcancer (NSCLC) including those unlikely to respond to immunotherapy.